CMA says tribunal “wrong” to overturn pharma fine
The UK’s Competition Appeal Tribunal erred on the test required for the Competition and Markets Authority to fine drugmakers for excessive pricing, the authority’s counsel has argued.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10